136 related articles for article (PubMed ID: 18242011)
1. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
Tshuikina M; Nilsson K; Oberg F
Gene; 2008 Mar; 410(2):259-67. PubMed ID: 18242011
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
[TBL] [Abstract][Full Text] [Related]
3. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation immediately adjacent to active histone marking does not silence transcription.
Brinkman AB; Pennings SW; Braliou GG; Rietveld LE; Stunnenberg HG
Nucleic Acids Res; 2007; 35(3):801-11. PubMed ID: 17202157
[TBL] [Abstract][Full Text] [Related]
5. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
7. The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells.
Kubosaki A; Lindgren G; Tagami M; Simon C; Tomaru Y; Miura H; Suzuki T; Arner E; Forrest AR; Irvine KM; Schroder K; Hasegawa Y; Kanamori-Katayama M; Rehli M; Hume DA; Kawai J; Suzuki M; Suzuki H; Hayashizaki Y
Mol Immunol; 2010 Aug; 47(14):2295-302. PubMed ID: 20573402
[TBL] [Abstract][Full Text] [Related]
8. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
[TBL] [Abstract][Full Text] [Related]
9. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
[TBL] [Abstract][Full Text] [Related]
10. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse.
Vu TH; Li T; Hoffman AR
Hum Mol Genet; 2004 Oct; 13(19):2233-45. PubMed ID: 15294879
[TBL] [Abstract][Full Text] [Related]
11. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
12. Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.
Szalmás A; Bánáti F; Koroknai A; László B; Fehér E; Salamon D; Gergely L; Minárovits J; Kónya J
Eur J Cancer; 2008 May; 44(7):1030-8. PubMed ID: 18378443
[TBL] [Abstract][Full Text] [Related]
13. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
Lee BM; Mahadevan LC
J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
Lee KY; Geng H; Ng KM; Yu J; van Hasselt A; Cao Y; Zeng YX; Wong AH; Wang X; Ying J; Srivastava G; Lung ML; Wang LD; Kwok TT; Levi BZ; Chan AT; Sung JJ; Tao Q
Oncogene; 2008 Sep; 27(39):5267-76. PubMed ID: 18469857
[TBL] [Abstract][Full Text] [Related]
15. Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the epsilon-, gamma-, and beta-globin gene promoters in Papio anubis.
Lavelle D; Vaitkus K; Hankewych M; Singh M; DeSimone J
Blood Cells Mol Dis; 2006; 36(2):269-78. PubMed ID: 16527500
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
17. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
[TBL] [Abstract][Full Text] [Related]
18. 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene.
Wada H; Kagoshima M; Ito K; Barnes PJ; Adcock IM
Biochem Biophys Res Commun; 2005 May; 331(1):93-9. PubMed ID: 15845363
[TBL] [Abstract][Full Text] [Related]
19. [Silencing of ICSBP/IRF8 expression in U226 cells and bone marrow mononuclear cells from patients with multiple myeloma].
Jia G; Ma YP; Zhang L; Lu YJ; Lu H; Chang MX; Zhang HP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1127-30. PubMed ID: 23114132
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
